Statistics for Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients
Total visits
| views | |
|---|---|
| Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients | 87 |
Total visits per month
| views | |
|---|---|
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
File Visits
| views | |
|---|---|
| Jan2021Bamlanivimab.pdf | 114 |
| java.util.UUID:5053732d-f6d0-43d0-a33c-b0786dbef7d9 | 42 |
| java.util.UUID:1b36522a-e192-4f7e-85e7-4bc3abbb5c12 | 8 |
| java.util.UUID:47747fe1-0ecd-4ac5-a207-63e43619bb0b | 5 |
Top country views
| views | |
|---|---|
| United States | 72 |
| China | 1 |
| Italy | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 44 |
| Houston | 9 |
| Fairfield | 4 |
| Indianapolis | 3 |
| Mount Laurel | 3 |
| Cambridge | 2 |
| Beijing | 1 |
| Laurel | 1 |
| Rome | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Tallahassee | 1 |